Algo version: 0.98b
TSH Biopharm Corporation is listed at the TWO Exchange
TSH Biopharm Corporation [8432.TWO]
TWO Sector: Healthcare Industry:Drug Manufacturers Specialty Generic

Is TSH Biopharm Corporation stock a buy?

What Is The Conclusion?

Right now our advanced algorithms say:

Do the analyst corps agree?

Interesting Questions and Easy Answers!

Yes, TSH Biopharm Corporation pays dividends. Last time was Friday 12th of July 2024 where the investors holding the stock on Monday 17th of June 2024 were paid TWD1.28 per share. Over the last 13 times between 2012 and 2024, TSH Biopharm Corporation has paid TWD27.3891 with an average of TWD2.11 per share.

Sorry, we do not have any analyst data for this ticker

We cannot find data for TSH Biopharm Corporation 10 years ago, but if you had invested on Friday 22nd of November 2019 when the price was TWD80.30, you would have made a loss of TWD-16.40 per share or -20.42%

Yes, the average daily trading liquidity for TSH Biopharm Corporation is TWD145 316 thousand. You should therefore be able to get in and out of your positions relatively fast.

TSH Biopharm Corporation has no real debt, which is good in periods of high inflation. With a high cash flow to debt ratio of 9.44, the company's ability to pay off the debt is good. TSH Biopharm Corporation has a good net profit margin of 9.44% and should have high tolerances against inflation.

We have calculated the inflation risk for TSH Biopharm Corporation to be low [0.1 of 1]

US inflation for August 2024 was 0.19%. Over the last 12 months, the US inflation is 2.59%. The 10-year treasury yield that indicates the future interest level is currently 4.41 and is up 0.05 over the last 30 days.